Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07419269

Comparison of Customized Allogenic Versus Autogenous Bone Block Graft for Alveolar Ridge Augmentation

The aim of this study is to determine whether jawbone augmentations using allogeneic and autogenous bone blocks lead to comparable three-dimensional clinical and radiological outcomes.

In addition, the study seeks to investigate whether there are differences regarding safety, biocompatibility, complications, and PROMs.

Furthermore, it aims to clarify whether differences exist between the two groups with respect to implant condition (one year after implantation and during annual follow-ups for up to five years).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Dental Medicine and Oral Health, Division of Oral Surgery and Orthodontics, Medical University of Graz

Graz, Styria, 8010, Austria

Location status: Recruiting

Location contact

Michael Payer, Assoz.Prof.

CONTACT

[email protected]

+4331638580659

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1-4 missing teeth that need to be replaced with dental implants
  • Bone ridge width insufficient for dental implant placement; <5 mm of width as measured in a cone beam computed tomography at the ideal prosthetic position
  • Medically healthy with no known allergies to antibiotics
  • Non-smoker or light smoker (< 10) or previous smoker who had quit for 5 years or more
  • Periodontal health, as confirmed by clinical examination (Full mouth bleeding score and full mouth plaque score < 25%) and at least one neighboring natural tooth to the defect site(s)
  • Age of 18 or above

Exclusion criteria

  • All contraindications against implant treatment or augmentative procedures (e.g., advanced systemic diseases, corticosteroid medication, immunodeficiency, pregnancy, intention to become pregnant, breastfeeding, lack of safe contraception)
  • Treatments or diseases that may have an effect on bone turnover or the bone itself or non-mineralized tissue metabolism (e.g., bisphosphonates or local radiotherapy, skeletal immaturity)
  • Pathological fractures such as those observed in (but not limited to) Paget's disease or in metastatic bone diseases
  • Any active malignancy or patient undergoing treatment for a malignancy Study protocol: IndiALLO Version 4/19.03.2025 Page 9 von 32
  • Contraindications to the class of drugs under study, e.g., known hypersensitivity or allergy to class of drugs or the investigational product
  • Persistent compartment syndrome or neurovascular residua of compartment syndrome

Treatment and study plan

Alveolar socket preservation with graft and flap surgery

Procedure

Partially edentulous patients in need of implant therapy and presenting an insufficient bone volume (horizontal ridge width <5mm) to allow placing a standard diameter implant defect-free in a prosthetically ideal position will be included.

In the control group, the blocks will be adapted to the defect site morphology. With a small drill, holes for fixation will be prepared and the bone blocks will be immobilized with one or two screws. Subsequently, a layer of bone particles will be applied if needed to cover the autogenous bone and to fill up voids.

allogenic bone block augmentation

Procedure

Partially edentulous patients in need of implant therapy and presenting an insufficient bone volume (horizontal ridge width <5mm) to allow placing a standard diameter implant defect-free in a prosthetically ideal position.

Based on CT/CBCT scans of the patient, the allogenic bone block has already been virtually designed using 3D CAD/CAM technology prior to surgery.

The individually milled bone graft Botiss maxgraft® bonebuilder (allogenic bone block), optional addition of MinerOss® A (allogenic bone granules) will then be covered with Argonaut® (porcine collagenbased membrane).

Primary outcomes

  1. ridge width gain in mm

    Time frame: at screening after augementation (= day 0) 180 days past augmentation (=implantation) 1 year after 2nd stage surgery 2 years after 2nd stage surgery 3 years after 2nd stage surgery 4 years after 2nd stage surgery 5 years after 2nd stage surgery

    • Clinical bone ridge width gain
    • Radiological bone ridge width gain

Study contacts

Contact information is provided by the study sponsor or research team.

Michael Payer, Assoz.Prof.

CONTACT

[email protected]

+4331638580659

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Registry information

Acronym: IndiALLO

Important dates

Study start
2025
Primary completion
2027
Study completion
2032
First posted
Feb 18, 2026
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.